BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35699333)

  • 21. Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review.
    Matsumoto T; Kusabiraki R; Arisawa A; Fujiki T; Noda A; Tanaka A; Yamamoto N; Aihara K; Yamaoka S; Mishima M
    Intern Med; 2021 Jun; 60(11):1785-1788. PubMed ID: 33390493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural-functional dissociation in presumed ethambutol optic neuropathy.
    Masvidal D; Parrish RK; Lam BL
    J Neuroophthalmol; 2010 Dec; 30(4):305-10. PubMed ID: 20592624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level.
    Kim KL; Park SP
    Cutan Ocul Toxicol; 2016 Sep; 35(3):228-32. PubMed ID: 26361935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual function in recovered ethambutol optic neuropathy.
    Woung LC; Jou JR; Liaw SL
    J Ocul Pharmacol Ther; 1995; 11(3):411-9. PubMed ID: 8590273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethambutol/Linezolid Toxic Optic Neuropathy.
    Libershteyn Y
    Optom Vis Sci; 2016 Feb; 93(2):211-7. PubMed ID: 26636399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern electroretinogram and visual evoked cortical potential in ethambutol optic neuropathy.
    Kakisu Y; Adachi-Usami E; Mizota A
    Doc Ophthalmol; 1987 Dec; 67(4):327-34. PubMed ID: 3454316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy.
    Kinoshita J; Iwata N; Maejima T; Kimotsuki T; Yasuda M
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7052-62. PubMed ID: 22956619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study.
    Goyal JL; De Sarmi ; Singh NP; Bhatia A
    J Commun Dis; 2003 Dec; 35(4):230-43. PubMed ID: 15909750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of N95 amplitude of pattern electroretinogram measured from baseline to N95 trough in the traumatic optic neuropathy.
    Kim KH; Kim US
    Jpn J Ophthalmol; 2019 May; 63(3):284-288. PubMed ID: 30848395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset: A case report.
    Sheng WY; Wu SQ; Su LY; Zhu LW
    World J Clin Cases; 2022 Jan; 10(2):663-670. PubMed ID: 35097092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-Treatment With Ethambutol After Toxic Optic Neuropathy.
    Bouffard MA; Nathavitharana RR; Yassa DS; Torun N
    J Neuroophthalmol; 2017 Mar; 37(1):40-42. PubMed ID: 27636749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on ethambutol optic neuropathy.
    Fraunfelder FW; Sadun AA; Wood T
    Expert Opin Drug Saf; 2006 Sep; 5(5):615-8. PubMed ID: 16907651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular toxicity among patients taking anti-tubercular treatment.
    Sitaula S; Sitaula RK; Thapa S; Chapagain S; Dahal HN
    Nepal J Ophthalmol; 2022 Jul; 14(28):4-15. PubMed ID: 37609961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal Ganglion Cell Layer Analysis by Optical Coherence Tomography in Toxic and Nutritional Optic Neuropathy.
    Vieira LM; Silva NF; Dias dos Santos AM; dos Anjos RS; Pinto LA; Vicente AR; Borges BI; Ferreira JP; Amado DM; da Cunha JP
    J Neuroophthalmol; 2015 Sep; 35(3):242-5. PubMed ID: 25724010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular ethambutol toxicity.
    Melamud A; Kosmorsky GS; Lee MS
    Mayo Clin Proc; 2003 Nov; 78(11):1409-11. PubMed ID: 14601701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular Toxicity of Ethambutol During Both Intensive and Continuation Phases of Anti-Tubercular Therapy in Children.
    Mane SS; Mandal A; Pustake M; Ali MK; Yadav N
    Indian Pediatr; 2022 Nov; 59(11):863-866. PubMed ID: 36370014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual outcomes of toxic optic neuropathy secondary to Ethambutol: A retrospective observational study from India, an endemic country.
    Ambika S; Lakshmi KP; Gopal M; Noronha OV
    Indian J Ophthalmol; 2022 Sep; 70(9):3388-3392. PubMed ID: 36018127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy.
    Lai TY; Chan WM; Lam DS; Lim E
    Br J Ophthalmol; 2005 Jun; 89(6):774-5. PubMed ID: 15923521
    [No Abstract]   [Full Text] [Related]  

  • 39. Alterations of the outer retina in non-arteritic anterior ischaemic optic neuropathy detected using spectral-domain optical coherence tomography.
    Ackermann P; Brachert M; Albrecht P; Ringelstein M; Finis D; Geerling G; Aktas O; Guthoff R
    Clin Exp Ophthalmol; 2017 Jul; 45(5):496-508. PubMed ID: 28133888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial retinal nerve fiber layer changes in patients with toxic optic neuropathy associated with antituberculosis pharmacotherapy.
    Kim YK; Hwang JM
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):531-5. PubMed ID: 20028260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.